Ganoderic acid and its derivatives as cholesterol synthesis inhibitors

Chem Pharm Bull (Tokyo). 1989 Feb;37(2):531-3. doi: 10.1248/cpb.37.531.

Abstract

Oxygenated lanosterol derivatives, which were isolated from Ganoderma lucidum (Polyporaceae) or their derivatives obtained by chemical conversion, were tested for their effect on cholesterol biosynthesis from 24,25-dihydrolanosterol by rat hepatic subcellular 10,000 x g supernatant fraction. The sterol (VI, 40 microM) with 7-oxo and 15 alpha-hydroxy groups potently inhibited the synthesis of cholesterol from [24,25-3H]-24,25-dihydrolanosterol (18 microM).

MeSH terms

  • Animals
  • Anticholesteremic Agents / pharmacology*
  • Cholesterol / biosynthesis*
  • In Vitro Techniques
  • Lanosterol / analogs & derivatives*
  • Lanosterol / biosynthesis
  • Lanosterol / pharmacology
  • Liver / drug effects
  • Liver / metabolism
  • Male
  • Polyporaceae / metabolism
  • Rats

Substances

  • Anticholesteremic Agents
  • Lanosterol
  • Cholesterol